Ossiam grew its position in The Clorox Company (NYSE:CLX - Free Report) by 438.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 83,454 shares of the company's stock after purchasing an additional 67,953 shares during the period. Ossiam owned approximately 0.07% of Clorox worth $13,554,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently modified their holdings of CLX. Brooklyn Investment Group boosted its position in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after acquiring an additional 95 shares during the last quarter. Redwood Park Advisors LLC acquired a new position in Clorox during the fourth quarter worth $26,000. Millstone Evans Group LLC bought a new position in Clorox in the fourth quarter valued at $31,000. Asset Planning Inc acquired a new stake in Clorox in the 4th quarter valued at $32,000. Finally, GKV Capital Management Co. Inc. bought a new stake in Clorox during the 4th quarter worth about $32,000. 78.53% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
CLX has been the topic of a number of recent research reports. JPMorgan Chase & Co. lowered their target price on Clorox from $173.00 to $151.00 and set a "neutral" rating on the stock in a research report on Friday, April 11th. StockNews.com cut shares of Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. DA Davidson cut their price target on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research note on Wednesday, February 5th. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Finally, Evercore ISI boosted their price target on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $153.83.
View Our Latest Stock Analysis on CLX
Clorox Price Performance
Shares of NYSE CLX traded down $0.70 during mid-day trading on Thursday, hitting $138.42. 625,711 shares of the stock traded hands, compared to its average volume of 1,300,183. The firm has a 50 day simple moving average of $146.01 and a two-hundred day simple moving average of $155.99. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The company has a market cap of $17.05 billion, a PE ratio of 37.82, a price-to-earnings-growth ratio of 2.62 and a beta of 0.61.
Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the business posted $2.16 earnings per share. As a group, equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.
Clorox Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.53%. Clorox's dividend payout ratio (DPR) is currently 133.33%.
Clorox Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories

Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.